Episode Details
Back to Episodes
Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure
Published 2 years, 7 months ago
Description
This is part one of a discussion focused upon data bias, accuracy, access and the future of AI in drug development. Topics explored are ROI, human bias, data challenges, data management plans, and human expertise.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Paul Agapow, Director of Innovation, Data Science and Strategy, GlaxoSmithKline
Mike King, Senior Director of Product and Strategy, IQVIA
Nindhana Paranthaman, Executive Medical Director, Exelixis
Moritz von Stosch, Chief Information Officer, DataHow